Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Other Non-Current Liabilities: 2015-2017

  • Viking Therapeutics' Other Non-Current Liabilities fell 76.78% to $47,113 in Q1 2017 from the same period last year, while for Mar 2017 it was $47,113, marking a year-over-year decrease of 76.78%. This contributed to the annual value of $183,611 for FY2015, which is N/A change from last year.
  • According to the latest figures from Q1 2017, Viking Therapeutics' Other Non-Current Liabilities is $47,113, which was down 76.78% from $202,882 recorded in Q1 2016.
  • In the past 5 years, Viking Therapeutics' Other Non-Current Liabilities registered a high of $202,882 during Q1 2016, and its lowest value of $47,113 during Q1 2017.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $183,611 (2015), whereas its average is $144,535.
  • Data for Viking Therapeutics' Other Non-Current Liabilities shows a maximum YoY tumbled of 76.78% (in 2017) over the last 5 years.
  • Over the past 3 years, Viking Therapeutics' Other Non-Current Liabilities (Quarterly) stood at $183,611 in 2015, then reached $202,882 in 2016, then tumbled by 76.78% to $47,113 in 2017.
  • Its last three reported values are $47,113 in Q1 2017, $202,882 for Q1 2016, and $183,611 during Q4 2015.